2026
Families USA Statement for the Record for the Energy and Commerce Health Subcommittee Hearing on Combatting Medicare and Medicaid Fraud
Families USA submitted a statement for the record for the March 17 Energy and Commerce Oversight & Investigations Subcommittee hearing “Protecting Patients and Safeguarding Taxpayer Dollars: The...
View More
Families USA Submits Comment Letter on Notice of Benefit and Payment Parameters (NBPP) Proposed Rule
Families USA submitted comments on the Centers for Medicare and Medicaid Services (CMS) 2027 Notice of Benefit and Payment Parameters (NBPP) proposed rule. Many of the policies proposed in the 2027 NB...
View More
The Battle Over Mifepristone Access in 2026
Mifepristone, commonly known as Mife, is a safe and effective medication approved by the U.S. Food and Drug Administration (FDA) more than 25 years ago. It has been used by millions of patients in the...
View More
Virginia Has the Opportunity to Lead on Lowering Prescription Drug Costs
The high cost of prescription drugs continues to strain families and state budgets alike. Now, Virginia has the opportunity to take a major step forward in lowering drug costs for families at the stat...
View More
Families USA Submits Testimony in Support of LD 2196 to Lower Health Insurance Costs and Reduce Barriers to Care
On March 5, 2026, Sophia Tripoli, senior director of health policy at Families USA, submitted written testimony to the Maine Joint Standing Committee on Health and Human Services, in support of LD 21...
View More
Higher Deductibles, More Barriers, Fewer Protections: How the New Marketplace Rule Would Further Erode Access to Affordable, Quality Health Coverage
People who buy coverage individually through the marketplace will be negatively impacted by new regulations proposed by the Trump Administration, which would promote plans with higher deductibles and ...
View More
Families USA Submits Comment Letter on Proposed Transparency in Coverage (TiC) Rule
Families USA, on behalf of the Consumers First steering committee, submitted comments on the Centers for Medicare & Medicaid Services (CMS) proposed Transparency in Coverage (TiC) rule. Consumers...
View More
Families USA Comment on GUARD Drug Pricing Model
Families USA submitted comment on the Centers for Medicare & Medicaid Services (CMS) model GUARD (Guarding U.S. Medicare Against Rising Drug Costs). Families USA supports the broader efforts to...
View MoreFamilies USA Submits Comment Letter on Proposed Rule Blocking Access to Gender-Affirming Care
Families USA submitted comments on the Centers for Medicare & Medicaid Services (CMS) proposed rule Medicare and Medicaid Programs; Hospital Conditions of Participation: Limiting Participation Bas...
View More
The Trump Administration’s Latest Attack on Medically Necessary, Gender-Affirming Care
The Trump Administration’s Latest Attack on Medically Necessary, Gender- Affirming Care The Trump administration is continuing its attacks on access to health care for transgender Americans, ...
View More